Roche Holding AG (OTCMKTS:RHHBY) Stock Has Average Target Price of $60.00 According to Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $60.00.

A number of research firms have recently weighed in on RHHBY. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price target on the stock in a report on Friday, August 7th. HSBC restated a “hold” rating on shares of Roche in a research report on Thursday, September 10th. UBS Group cut Roche from a “strong-buy” rating to a “hold” rating in a report on Monday, November 2nd. Zacks Research raised Roche from a “strong sell” rating to a “hold” rating in a report on Monday, August 24th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Roche from a “hold” rating to a “buy” rating in a research report on Friday, October 23rd.

Institutional Trading of Roche

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. S&CO Inc. raised its position in shares of Roche by 163.0% during the 1st quarter. S&CO Inc. now owns 140,551 shares of the company’s stock worth $6,880,000 after purchasing an additional 87,107 shares during the last quarter. Opal Capital LLC bought a new position in shares of Roche during the 1st quarter worth approximately $4,448,000. First Command Advisory Services Inc. raised its position in Roche by 188.7% in the 3rd quarter. First Command Advisory Services Inc. now owns 37,694 shares of the company’s stock valued at $1,956,000 after buying an additional 24,639 shares during the last quarter. Associated Banc Corp acquired a new stake in Roche in the third quarter valued at about $1,740,000. Finally, GAMMA Investing LLC lifted its position in Roche by 15.3% in the 3rd quarter. GAMMA Investing LLC now owns 33,458 shares of the company’s stock valued at $1,736,000 after acquiring an additional 4,443 shares in the last quarter.

Roche Stock Down 0.1%

Shares of RHHBY opened at $59.37 on Friday. The stock has a 50 day moving average price of $55.86 and a 200 day moving average price of $53.88. The company has a current ratio of 1.23, a quick ratio of 0.95 and a debt-to-equity ratio of 0.69. Roche has a one year low of $41.43 and a one year high of $61.49.

Roche Company Profile

Roche is a Swiss healthcare company with two main businesses: pharmaceuticals and diagnostics. Founded in Basel in 1896, the company develops and commercializes medicines and provides diagnostic tests, instruments, and digital health solutions.

Its pharmaceutical research and products span areas including oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Its diagnostics business serves clinical laboratories, hospitals, healthcare providers, and patients with tools used to detect and monitor a range of medical conditions.

Headquartered in Basel, Roche operates in markets around the world.